Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Talati, Naasha J ^a   Seybold, Ulrich ^a,b   Humphrey, Bianca ^a   Aina, Abiola ^a   Tapia, Jane ^a   Weinfurter, Paul ^c   Albalak, Rachel ^c   Blumberg, Henry M ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; STANDARD;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GEORGIA; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 61749083640     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-15     Document Type: Article

References (26)

1. Dye C Scheele S Dolin P Pathania V Raviglione MC Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project Jama 1999, 282:677-686. 10.1001/jama.282.7.677 10517722
2. Blumberg HM Leonard MK Jr Jasmer RM Update on the treatment of tuberculosis and latent tuberculosis infection Jama 2005, 293:2776-2784. 10.1001/jama.293.22.2776 15941808
3. Ferebee SH Controlled chemoprophylaxis trials in tuberculosis. A general review Bibl Tuberc 1970, 26:28-106. 4903501
4. Selwyn PA Hartel D Lewis VA Schoenbaum EE Vermund SH Klein RS Walker AT Friedland GH A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection N Engl J Med 1989, 320:545-550. 2915665
5. Kaplan JE Masur H Holmes KK Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America MMWR Recomm Rep 2002, 51(RR-8):1-52. 12081007
6. Taylor Z Nolan CM Blumberg HM Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America MMWR Recomm Rep 2005, 54:1-81. 16267499
7. Pape JW Jean SS Ho JL Hafner A Johnson WD Jr Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection Lancet 1993, 342:268-272. 10.1016/0140-6736(93)91817-6 8101302
8. Pai M Riley LW Colford JM Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review Lancet Infect Dis 2004, 4:761-776. 10.1016/S1473-3099(04)01206-X 15567126
9. Pai M Kalantri S Dheda K New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis Expert Rev Mol Diagn 2006, 6:413-422. 10.1586/14737159.6.3.413 16706743
10. Harboe M Oettinger T Wiker HG Rosenkrands I Andersen P Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG Infect Immun 1996, 64:16-22. 173721 8557334
11. Menzies D Pai M Comstock G Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research Ann Intern Med 2007, 146:340-354. 17339619
12. Mazurek GH Jereb J Lobue P Iademarco MF Metchock B Vernon A Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States MMWR Recomm Rep 2005, 54:49-55. 16357824
13. Rangaka MX Wilkinson KA Seldon R Van Cutsem G Meintjes GA Morroni C Mouton P Diwakar L Connell TG Maartens G Wilkinson RJ Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection Am J Respir Crit Care Med 2007, 175:514-520. 10.1164/ rccm.200610-1439OC 17158278
14. Chapman AL Munkanta M Wilkinson KA Pathan AA Ewer K Ayles H Reece WH Mwinga A Godfrey-Faussett P Lalvani A Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells Aids 2002, 16:2285-2293. 10.1097/00002030-200211220-00008 12441800
15. Luetkemeyer AF Charlebois ED Flores LL Bangsberg DR Deeks SG Martin JN Havlir DV Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals Am J Respir Crit Care Med 2007, 175:737-742. 1899289 17218620 10.1164/rccm.200608-1088OC
16. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society MMWR Recomm Rep 2000, 49(RR-6):1-51. 10881762
17. Pai M Gokhale K Joshi R Dogra S Kalantri S Mendiratta DK Narang P Daley CL Granich RM Mazurek GH et al. Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing Jama 2005, 293:2746-2755. 10.1001/jama.293.22.2746 15941804
18. Jones S de Gijsel D Wallach FR Gurtman AC Shi Q Sacks H Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals Int J Tuberc Lung Dis 2007, 11:1190-1195. 17958980
19. Brock I Ruhwald M Lundgren B Westh H Mathiesen LR Ravn P Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test Respir Res 2006, 7:56. 1523341 16579856 10.1186/ 1465-9921-7-56
20. Karam F Mbow F Fletcher H Senghor CS Coulibaly KD Lefevre AM Ngom Gueye NF Dieye T Sow PS Mboup S Lienhardt C Sensitivity of IFN-gamma Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression PLoS ONE 2008, 3:e1441. 2174527 18197251 10.1371/journal.pone.0001441
21. Ellner JJ Hirsch CS Whalen CC Correlates of protective immunity to Mycobacterium tuberculosis in humans Clin Infect Dis 2000, 30(Suppl 3):S279-282. 10.1086/313874 10875800
22. Fisk TL Hon HM Lennox JL Fordham von Reyn C Horsburgh CR Jr Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy Aids 2003, 17:1102-1104. 10.1097/ 00002030-200305020-00027 12700468
23. Liebeschuetz S Bamber S Ewer K Deeks J Pathan AA Lalvani A Diagnosis of tuberculosis in South African children with a T-cell-based assay: A prospective cohort study Lancet 2004, 364:2196-2203. 10.1016/ S0140-6736(04)17592-2 15610806
24. Ewer K Deeks J Alvarez L Bryant G Waller S Andersen P Monk P Lalvani A Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak Lancet 2003, 361:1168-1173. 10.1016/S0140-6736(03)12950-9 12686038
25. Piana F Codecasa LR Cavallerio P Ferrarese M Migliori GB Barbarano L Morra E Cirillo DM Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients Eur Respir J 2006, 28:31-34. 10.1183/09031936.06.00110205 16540502
26. Ferrara G Losi M D'Amico R Roversi P Piro R Meacci M Meccugni B Dori IM Andreani A Bergamini BM et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study Lancet 2006, 367:1328-1334. 10.1016/ S0140-6736(06)68579-6 16631911